Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Nakata B

Collect these papers and discover other ones on Labmeeting. Learn more.

Vitamin D receptor expression is associated with colon cancer in ulcerative colitis.

+ cite this

+ View Abstract

Wada K, Tanaka H, Maeda K, Inoue T, Noda E, Amano R, Kubo N, Muguruma K, Yamada N, Yashiro M, Sawada T, Nakata B, Ohira M, and Hirakawa K

Oncology reports 22(5):1021-5, 2009 Nov - Who cited this? | PubMed ID: 19787215 | Fulltext

HER2 overexpression correlates with survival after curative resection of pancreatic cancer.

+ cite this

+ View Abstract

Komoto M, Nakata B, Amano R, Yamada N, Yashiro M, Ohira M, Wakasa K, and Hirakawa K

Cancer science 100(7):1243-7, 2009 Jul - Who cited this? | PubMed ID: 19432892 | Fulltext

Gemcitabine sensitivity-related mRNA expression in endoscopic ultrasound-guided fine-needle aspiration biopsy of unresectable pancreatic cancer.

+ cite this

+ View Abstract

Ashida R, Nakata B, Shigekawa M, Mizuno N, Sawaki A, Hirakawa K, Arakawa T, and Yamao K

Journal of experimental & clinical cancer research : CR 28:83, 2009 - Who cited this? | PubMed ID: 19531250 | Fulltext

Chemokine receptor CCR7 expression correlates with lymph node metastasis in pancreatic cancer.

+ cite this

+ View Abstract

Nakata B, Fukunaga S, Noda E, Amano R, Yamada N, and Hirakawa K

Oncology 74(1-2):69-75, 2008 - Who cited this? | PubMed ID: 18544997 | Fulltext

Efficacy of S-1 for gastric cancer patients with positive peritoneal lavage cytology.

+ cite this

+ View Abstract

Ako E, Ohira M, Yamashita Y, Kubo N, Muguruma K, Yashiro M, Sawada T, Nakata B, Kato Y, and Hirakawa K

Hepato-gastroenterology 55(86-87):1939-42, 2008 - Who cited this? | PubMed ID: 19102427 | Fulltext

Comparison of clinicopathological characteristics of curatively resected pancreatic head and body/tail ductal cancers.

+ cite this

+ View Abstract

Nakata B, Yamada N, Amano R, Tendo M, Inoue M, Sakurai K, and Hirakawa K

Journal of experimental & clinical cancer research : CR 26(4):459, 2007 Dec - Who cited this? | PubMed ID: 18365539 | Fulltext

A Phase I Study of Combination Therapy of the Oral Fluorinated Pyrimidine Compound S-1 with Low-dose Cisplatin Twice-a-week Administration (JFMC27-9902 Step2) in Patients with Advanced Gastric Cancer Using a Continual Reassessment Method.

+ cite this

+ View Abstract

Morita S, Nakata B, Tsuji A, Mitachi Y, Shirasaka T, Saji S, Ohashi Y, Sakamoto J, and Hirakawa K

Japanese journal of clinical oncology 37(12):924-9, 2007 Dec - Who cited this? | PubMed ID: 18211983 | Fulltext

Alternative pharmacokinetics of S-1 components, 5-fluorouracil, dihydrofluorouracil and alpha-fluoro-beta-alanine after oral administration of S-1 following total gastrectomy.

+ cite this

+ View Abstract

Kim WY, Nakata B, and Hirakawa K

Cancer science 98(10):1604-8, 2007 Oct - Who cited this? | PubMed ID: 17683513 | Fulltext

Continuous infusion of 5-fluorouracil with versus without low-dose, consecutive administration of cisplatin in advanced colorectal cancer. A prospective randomized phase II study.

+ cite this

+ View Abstract

Nakata B, Sowa M, Tsuji A, Kamano T, Sasaki K, Fukunaga Y, Takahashi M, Tsujitani S, Mikami Y, Mitachi Y, Nishimura S, Araki H, Yamamitsu S, Hirakawa K, Tominaga S, Shirasaka T,

(show remaining authors)

Journal of experimental & clinical cancer research : CR 26(1):51-60, 2007 Mar - Who cited this? | PubMed ID: 17550132 | Fulltext

Moderate neutropenia with S-1 plus low-dose cisplatin may predict a more favourable prognosis in advanced gastric cancer.

+ cite this

+ View Abstract

Nakata B, Tsuji A, Mitachi Y, Yamamitsu S, Hirata K, Takeuchi T, Shirasaka T, and Hirakawa K

Clinical oncology (Royal College of Radiologists (Great Britain)) 18(9):678-83, 2006 Nov - Who cited this? | PubMed ID: 17100153 | Fulltext

[S-1+Low-Dose CDDP].

+ cite this

+ View Abstract

Nakata B, Tsuji A, and Hirakawa K

Gan to kagaku ryoho. Cancer & chemotherapy 33 Suppl 1:68-74, 2006 Jun - Who cited this? | PubMed ID: 16897975 | Fulltext

Transplatin, a cisplatin trans-isomer, may enhance the anticancer effect of 5-fluorouracil.

+ cite this

+ View Abstract

Nakata B, Yamagata S, Kanehara I, Shirasaka T, and Hirakawa K

Journal of experimental & clinical cancer research : CR 25(2):195-200, 2006 Jun - Who cited this? | PubMed ID: 16918130 | Fulltext

Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori.

+ cite this

+ View Abstract

Komoto M, Tominaga K, Nakata B, Takashima T, Inoue T, and Hirakawa K

Journal of experimental & clinical cancer research : CR 25(2):283-5, 2006 Jun - Who cited this? | PubMed ID: 16918142 | Fulltext

[Risk factor for pancreatic cancer--alcoholic abuse].

+ cite this

Nishino H, Yamada N, Nakata B, and Hirakawa K

Nippon rinsho. Japanese journal of clinical medicine 64 Suppl 1:14-7, 2006 Jan - Who cited this? | PubMed ID: 16457212 | Fulltext

Caspase-8 is scarcely silenced and its activity is well correlated with the anticancer effect of tumor necrosis factor-related apoptosis-inducing ligand in gastric cancer cells.

+ cite this

+ View Abstract

Kanehara I, Nakata B, and Hirakawa K

Oncology reports 14(5):1249-53, 2005 Nov - Who cited this? | PubMed ID: 16211292 | Fulltext

[A case of gastric cancer with peritoneal recurrence which developed during adjuvant administration of TS-1 showing complete response by weekly docetaxel regimen].

+ cite this

+ View Abstract

Takashima T, Nakata B, Komoto M, Nomura S, Sawada T, Ohira M, Ishikawa T, and Hirakawa K

Gan to kagaku ryoho. Cancer & chemotherapy 32(7):1041-4, 2005 Jul - Who cited this? | PubMed ID: 16044970 | Fulltext

[Changes in tumor marker levels as a predictor of gemcitabine effect on patients with unresectable or recurrent pancreatic cancer].

+ cite this

+ View Abstract

Tendo M, Nakata B, Nishino H, Inoue M, Kosaka K, Amano R, Yamada N, and Hirakawa K

Gan to kagaku ryoho. Cancer & chemotherapy 32(6):795-8, 2005 Jun - Who cited this? | PubMed ID: 15984518 | Fulltext

[A case of anthracycline and taxane-resistant breast cancer with life-thereatening multiple liver metastases responding to oral combination chemotherapy by UFT, cyclophosphamide and medroxyprogesterone acetate].

+ cite this

+ View Abstract

Ishikawa T, Takashima T, Takagaki K, Ogawa Y, Onoda N, Nakata B, Kato Y, and Hirakawa K

Gan to kagaku ryoho. Cancer & chemotherapy 32(5):687-90, 2005 May - Who cited this? | PubMed ID: 15918574 | Fulltext

Prognostic predictive value of endoscopic ultrasound findings for invasive ductal carcinomas of pancreatic head.

+ cite this

+ View Abstract

Nakata B, Nishino H, Ogawa Y, Yokomatsu H, Kawasaki F, Kosaka K, Wada T, Suto R, Montani A, and Hirakawa K

Pancreas 30(3):200-5, 2005 Apr - Who cited this? | PubMed ID: 15782094 | Fulltext

Dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 may be effective against peritoneal dissemination in gastric cancer.

+ cite this

+ View Abstract

Yamagata S, Nakata B, and Hirakawa K

Oncology reports 12(5):973-8, 2004 Nov - Who cited this? | PubMed ID: 15492780 | Fulltext

[Combination therapy of a novel oral fluorouracil derivative TS-1 with low-dose cisplatin for recurrent and very advanced gastric cancer].

+ cite this

+ View Abstract

Nakata B and Hirakawa K

Gan to kagaku ryoho. Cancer & chemotherapy 31(12):1962-8, 2004 Nov - Who cited this? | PubMed ID: 15570921 | Fulltext

A case of osteoclast-type giant cell tumor of the pancreas with high-frequency microsatellite instability.

+ cite this

+ View Abstract

Osaka H, Yashiro M, Nishino H, Nakata B, Ohira M, and Hirakawa K

Pancreas 29(3):239-41, 2004 Oct - Who cited this? | PubMed ID: 15367891 | Fulltext

Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer.

+ cite this

+ View Abstract

Nakata B, Takashima T, Ogawa Y, Ishikawa T, and Hirakawa K

British journal of cancer 91(5):873-8, 2004 Aug 31 - Who cited this? | PubMed ID: 15280913 | Fulltext

Combination phase I trial of a novel oral fluorouracil derivative S-1 with low-dose cisplatin for unresectable and recurrent gastric cancer (JFMC27-9902).

+ cite this

+ View Abstract

Nakata B, Mitachi Y, Tsuji A, Yamamitsu S, Hirata K, Shirasaka T, and Hirakawa K

Clinical cancer research : an official journal of the American Association for Cancer Research 10(5):1664-9, 2004 Mar 1 - Who cited this? | PubMed ID: 15014017 | Fulltext

Phase I/II study of combination therapy of oral fluorinated pyrimidine compound S-1 with low-dose cisplatin in patients with unresectable and/or recurrent advanced gastric cancer: a novel study design to evaluate safety and efficacy.

+ cite this

+ View Abstract

Morita S, Ohashi Y, Hirakawa K, Nakata B, Saji S, and Sakamoto J

Japanese journal of clinical oncology 34(3):159-61, 2004 Mar - Who cited this? | PubMed ID: 15078913 | Fulltext

[A case of gastric cancer with umbilical metastasis that responded to TS-1 with low-dose cis-platinum].

+ cite this

+ View Abstract

Takashima T, Yamagata S, Fukunaga S, Inoue T, Yashiro M, Nakata B, Nishiguchi Y, Kato Y, Ohira M, Ishikawa T, and Hirakawa K

Gan to kagaku ryoho. Cancer & chemotherapy 31(2):247-50, 2004 Feb - Who cited this? | PubMed ID: 14997761 | Fulltext

Differences in dihydropyrimidine dehydrogenase activities between gastric and colorectal cancer.

+ cite this

+ View Abstract

Nakata B, Muguruma K, Yamagata S, Yukimoto K, Maeda K, Nishiguchi Y, Ohira M, Kato Y, and Hirakawa K

Digestive diseases and sciences 49(1):60-4, 2004 Jan - Who cited this? | PubMed ID: 14992436 | Fulltext

Intraductal papillary-mucinous adenoma developed in the ventral pancreas in a patient with pancreas divisum.

+ cite this

+ View Abstract

Sakate Y, Ohira M, Maeda K, Yamada N, Nishihara T, Nakata B, Nishiguchi Y, Nishino H, and Hirakawa K

Journal of hepato-biliary-pancreatic surgery 11(5):366-70, 2004 - Who cited this? | PubMed ID: 15549440 | Fulltext

Immunohistochemical assessment for estrogen receptor and progesterone receptor status in breast cancer: analysis for a cut-off point as the predictor for endocrine therapy.

+ cite this

+ View Abstract

Ogawa Y, Moriya T, Kato Y, Oguma M, Ikeda K, Takashima T, Nakata B, Ishikawa T, and Hirakawa K

Breast cancer (Tokyo, Japan) 11(3):267-75, 2004 - Who cited this? | PubMed ID: 15550845 | Fulltext

Negative hMSH2 protein expression in pancreatic carcinoma may predict a better prognosis of patients.

+ cite this

+ View Abstract

Nakata B, Wang YQ, Yashiro M, Ohira M, Ishikawa T, Nishino H, Seki S, and Hirakawa K

Oncology reports 10(4):997-1000, 2003 - Who cited this? | PubMed ID: 12792759 | Fulltext

Oral UFT and cyclophosphamide combination chemotherapy for metastatic breast cancer.

+ cite this

+ View Abstract

Ogawa Y, Ishikawa T, Chung SH, Ikeda K, Takashima T, Onoda N, Nakata B, Nishiguchi Y, and Hirakawa K

Anticancer research 23(4):3453-7, 2003 - Who cited this? | PubMed ID: 12926089 | Fulltext

Very low incidence of microsatellite instability in intraductal papillary-mucinous neoplasm of the pancreas.

+ cite this

+ View Abstract

Nakata B, Yashiro M, Nishioka N, Aya M, Yamada S, Takenaka C, Ohira M, Ishikawa T, Nishino H, Wakasa K, Seki S, and Hirakawa K

International journal of cancer. Journal international du cancer 102(6):655-9, 2002 Dec 20 - Who cited this? | PubMed ID: 12448010 | Fulltext

Genetic alterations in adenoma-carcinoma sequencing of intraductal papillary-mucinous neoplasm of the pancreas.

+ cite this

+ View Abstract

Nakata B, Yashiro M, Nishioka N, Aya M, Yamada S, Takenaka C, Ohira M, Ishikawa T, Nishino H, Wakasa K, and Hirakawa K

International journal of oncology 21(5):1067-72, 2002 Nov - Who cited this? | PubMed ID: 12370756 | Fulltext

Prognostic value of microsatellite instability in resectable pancreatic cancer.

+ cite this

+ View Abstract

Nakata B, Wang YQ, Yashiro M, Nishioka N, Tanaka H, Ohira M, Ishikawa T, Nishino H, and Hirakawa K

Clinical cancer research : an official journal of the American Association for Cancer Research 8(8):2536-40, 2002 Aug - Who cited this? | PubMed ID: 12171881 | Fulltext

TGF-beta1 promotes liver metastasis of pancreatic cancer by modulating the capacity of cellular invasion.

+ cite this

+ View Abstract

Teraoka H, Sawada T, Yamashita Y, Nakata B, Ohira M, Ishikawa T, Nishino H, and Hirakawa K

International journal of oncology 19(4):709-15, 2001 Oct - Who cited this? | PubMed ID: 11562745 | Fulltext

Apoptosis and thymidylate synthase inductions by 5-fluorouracil in gastric cancer cells with or without p53 mutation.

+ cite this

+ View Abstract

Yukimoto K, Nakata B, Muguruma K, Yashiro M, Ohira M, Ishikawa T, Hino M, and Hirakawa K

International journal of oncology 19(2):373-8, 2001 Aug - Who cited this? | PubMed ID: 11445854 | Fulltext

Prognostic predictive value of 18F-fluorodeoxyglucose positron emission tomography for patients with pancreatic cancer.

+ cite this

+ View Abstract

Nakata B, Nishimura S, Ishikawa T, Ohira M, Nishino H, Kawabe J, Ochi H, and Hirakawa K

International journal of oncology 19(1):53-8, 2001 Jul - Who cited this? | PubMed ID: 11408922 | Fulltext

Diagnostic usefulness of FDG PET for pancreatic mass lesions.

+ cite this

+ View Abstract

Koyama K, Okamura T, Kawabe J, Nakata B, Chung KH, Ochi H, and Yamada R

Annals of nuclear medicine 15(3):217-24, 2001 Jun - Who cited this? | PubMed ID: 11545191 | Fulltext

A combination analysis of p53 and p21 in gastric carcinoma as a strong indicator for prognosis.

+ cite this

+ View Abstract

Ogawa M, Onoda N, Maeda K, Kato Y, Nakata B, Kang SM, Sowa M, and Hirakawa K

International journal of molecular medicine 7(5):479-83, 2001 May - Who cited this? | PubMed ID: 11295107 | Fulltext

The thoracoscopic approach for internal mammary nodes in breast cancer.

+ cite this

+ View Abstract

Ogawa Y, Ishikawa T, Ikeda K, Takemura S, Nakata B, Nishiguchi Y, Kato Y, and Hirakawa K

Surgical endoscopy 14(12):1149-52, 2000 Dec - Who cited this? | PubMed ID: 11148786 | Fulltext

Caspase-1 activity as a possible predictor of apoptosis induced by cisplatin in gastric cancer cells.

+ cite this

+ View Abstract

Muguruma K, Nakata B, Yanagawa K, Nitta A, Yashiro M, Onoda N, and Hirakawa K

International journal of molecular medicine 6(5):553-7, 2000 Nov - Who cited this? | PubMed ID: 11029523 | Fulltext

[Three cases of metastatic breast cancer, resistant to pre-chemo and/or endocrine therapy, markedly improved with UFT and cyclophosphamide oral combination therapy].

+ cite this

+ View Abstract

Ogawa Y, Ishikawa T, Ogisawa K, Ikeda K, Nagatsuka I, Matsumura Y, Takashima T, Yashiro M, Onoda N, Nakata B, Kato Y, and Hirakawa K

Gan to kagaku ryoho. Cancer & chemotherapy 27(13):2123-7, 2000 Nov - Who cited this? | PubMed ID: 11103246 | Fulltext

Evaluation of serum KL-6, a mucin-like glycoprotein, as a tumor marker for breast cancer.

+ cite this

+ View Abstract

Ogawa Y, Ishikawa T, Ikeda K, Nakata B, Sawada T, Ogisawa K, Kato Y, and Hirakawa K

Clinical cancer research : an official journal of the American Association for Cancer Research 6(10):4069-72, 2000 Oct - Who cited this? | PubMed ID: 11051258 | Fulltext

Serum CYFRA 21-1 is one of the most reliable tumor markers for breast carcinoma.

+ cite this

+ View Abstract

Nakata B, Ogawa Y, Ishikawa T, Ikeda K, Kato Y, Nishino H, and Hirakawa K

Cancer 89(6):1285-90, 2000 Sep 15 - Who cited this? | PubMed ID: 11002224 | Fulltext

Clinical significance of serum soluble intercellular adhesion molecule 1 in gastric cancer.

+ cite this

+ View Abstract

Nakata B, Hori T, Sunami T, Ogawa Y, Yashiro M, Maeda K, Sawada T, Kato Y, Ishikawa T, and Hirakawa K

Clinical cancer research : an official journal of the American Association for Cancer Research 6(3):1175-9, 2000 Mar - Who cited this? | PubMed ID: 10741749 | Fulltext

[Genome analyses for precancerous lesions in the gastrointestinal tract].

+ cite this

+ View Abstract

Sowa M and Nakata B

Gan to kagaku ryoho. Cancer & chemotherapy 27(3):335-40, 2000 Mar - Who cited this? | PubMed ID: 10740625 | Fulltext

Serum CA 125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma.

+ cite this

+ View Abstract

Nakata B, Hirakawa-YS Chung K, Kato Y, Yamashita Y, Maeda K, Onoda N, Sawada T, and Sowa M

Cancer 83(12):2488-92, 1998 Dec 15 - Who cited this? | PubMed ID: 9874453 | Fulltext

Expression of the mismatch repair gene hMSH2 in sporadic colorectal cancer.

+ cite this

+ View Abstract

Maeda K, Nishiguchi Y, Onoda N, Otani H, Nakata B, Yamada S, Okuno M, Sowa M, and Chung KH

International journal of oncology 13(6):1147-51, 1998 Dec - Who cited this? | PubMed ID: 9824623 | Fulltext

Thymidine phosphorylase activity in tumor correlates with venous invasion.

+ cite this

+ View Abstract

Nakata B, Chung KH, Kato Y, Yamashita Y, Onoda N, Maeda K, and Sowa M

International journal of molecular medicine 2(4):461-4, 1998 Oct - Who cited this? | PubMed ID: 9857235 | Fulltext

Changes in tumor marker levels as a predictor of chemotherapeutic effect in patients with gastric carcinoma.

+ cite this

+ View Abstract

Nakata B, Chung KH, Muguruma K, Yamashita Y, Inoue T, Matsuoka T, Onoda N, Kato Y, Sakurai M, and Sowa M

Cancer 83(1):19-24, 1998 Jul 1 - Who cited this? | PubMed ID: 9655288 | Fulltext

Search Google Scholar for Nakata B

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!